IMCCNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
IM Cannabis Corp.
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 30, 2026
$1.50+0.11 (+7.91%)
Close on Oct 19, 2026
IM Cannabis statistics
Financials through Dec 31, 2025, price-based ratios appear once a share price is available, median of Medicinal Chemicals & Botanical Products companies for comparison
Valuation
| Measure | IM Cannabis | Industry median |
|---|---|---|
| Market Cap | C$12.62M | C$123.83M |
| Enterprise Value | C$26.21M | C$113.12M |
| PS Ratio | 0.23 | 1.24 |
| P/FCF Ratio | 2.68 | |
| P/OCF Ratio | 2.68 | 4.66 |
Enterprise value
| Measure | IM Cannabis | Industry median |
|---|---|---|
| EV / Sales | 0.48 | 1.14 |
| EV / FCF | 5.57 |
Income (trailing twelve months)
| Measure | IM Cannabis | Industry median |
|---|---|---|
| Revenue | C$54.73M | C$28.08M |
| Gross Profit | C$9.69M | C$13.09M |
| Operating Income | -C$11.59M | -C$11.94M |
| Pretax Income | -C$11.66M | -C$10.05M |
| Net Income | -C$11.32M | |
| EBITDA | -C$11.59M | -C$10.30M |
Margins
| Measure | IM Cannabis | Industry median |
|---|---|---|
| Gross Margin | 17.7% | 41.6% |
| Operating Margin | -21.2% | -25.4% |
| Pretax Margin | -21.3% | -15.6% |
| Profit Margin | -20.7% | |
| EBITDA Margin | -21.2% | -16.8% |
| FCF Margin | 8.59% | -28.3% |
Returns
| Measure | IM Cannabis | Industry median |
|---|---|---|
| Return on Equity (ROE) | -1496.2% | |
| Return on Assets (ROA) | -31.9% | |
| Return on Invested Capital (ROIC) | -60.6% |
Growth
| Measure | IM Cannabis | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 1.30% | 4.81% |
| Revenue Growth (3Y CAGR) | 0.24% | 8.51% |
| Revenue Growth (5Y CAGR) | 28.1% | 19.9% |
Balance sheet
| Measure | IM Cannabis | Industry median |
|---|---|---|
| Cash & Short-Term Investments | C$2.73M | C$18.85M |
| Total Debt | C$16.21M | C$8.30M |
| Net Cash (Debt) | -C$13.48M | C$16.52M |
| Net Cash Per Share | -2.29 CAD | 0.25 CAD |
| Equity (Book Value) | -C$3.73M | |
| Book Value Per Share | -0.63 CAD | |
| Tangible Book Value | -C$6.84M | |
| Working Capital | -C$11.27M | C$15.82M |
Financial position
| Measure | IM Cannabis | Industry median |
|---|---|---|
| Current Ratio | 0.67 | 3.87 |
| Quick Ratio | 0.21 | 2.47 |
| Debt / FCF | 3.45 | |
| Interest Coverage | -3.31 | -52.25 |
Cash flow (trailing twelve months)
| Measure | IM Cannabis | Industry median |
|---|---|---|
| Operating Cash Flow | C$4.72M | -C$6.28M |
| Capital Expenditures | -C$13.00K | -C$685.52K |
| Free Cash Flow | C$4.70M | -C$10.42M |
| FCF Per Share | 0.80 CAD | -0.07 CAD |
Efficiency
| Measure | IM Cannabis | Industry median |
|---|---|---|
| Asset Turnover | 1.54 | 0.44 |
| Inventory Turnover | 12.04 | 2.74 |
| Revenue Per Employee | C$576.12K | C$469.57K |
| Profits Per Employee | -C$119.15K | |
| Employee Count | 95 | 26 |
Dividends and yields
| Measure | IM Cannabis | Industry median |
|---|---|---|
| Earnings Yield | -89.7% | |
| FCF Yield | 37.3% | -10.0% |
| Buyback Yield | -40.1% | -3.22% |
| Shareholder Yield | -40.1% | -3.22% |
Shares
| Measure | IM Cannabis | Industry median |
|---|---|---|
| Shares Outstanding | 5,894,810 | 74,643,400 |
| Float | 5,894,810 | 74,292,200 |
| Shares Held by Insiders | 0.00% | 0.00% |
Taxes
| Measure | IM Cannabis | Industry median |
|---|---|---|
| Income Tax | C$92.00K | C$0 |
Scores
| Measure | IM Cannabis | Industry median |
|---|---|---|
| Altman Z-Score | -11.61 | 0.35 |
| Piotroski F-Score | 4 |
Calculated by StockData from IM Cannabis's SEC filings. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.